Anne Davit-Spraul

Summary

Country: France

Publications

  1. ncbi Simple and fast quantification of nitisone (NTBC) using liquid chromatography-tandem mass spectrometry method in plasma of tyrosinemia type 1 patients
    Anne Davit-Spraul
    Biochemistry Unit, Hopital Bicetre, Assistance Publique Hopitaux de Paris, Le Kremlin Bicetre, France
    J Chromatogr Sci 50:446-9. 2012
  2. ncbi Progressive familial intrahepatic cholestasis
    Anne Davit-Spraul
    Biochemistry, Bicetre Hospital, University of Paris Sud XI, Assistance Publique Hopitaux de Paris, Paris, France
    Orphanet J Rare Dis 4:1. 2009
  3. ncbi Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies
    Anne Davit-Spraul
    Biochemistry Unit, CHU Bicetre, Assistance Publique Hopitaux de Paris, France
    Mol Genet Metab 104:137-43. 2011
  4. ncbi ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history
    Anne Davit-Spraul
    Biochemistry Unit, Hopital Bicetre, Assistance Publique, Hopitaux de Paris, Paris, France
    Hepatology 51:1645-55. 2010
  5. ncbi The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects
    Anne Davit-Spraul
    Biochemistry, University of Paris Sud 11, Assistance Publique Hopitaux de Paris, Le Kremlin Bicetre, France
    Semin Liver Dis 30:134-46. 2010
  6. ncbi Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2
    Emmanuel Gonzales
    Pediatric Hepatology and National Reference Centre for Rare Pediatric Liver Diseases, Bicêtre Universitary Hospital, Faculty of Medicine Paris Sud, University of Paris Sud 11, Assistance Publique Hopitaux de Paris, Le Kremlin Bicetre, France
    J Hepatol 57:695-8. 2012
  7. ncbi Hereditary fructose intolerance: frequency and spectrum mutations of the aldolase B gene in a large patients cohort from France--identification of eight new mutations
    Anne Davit-Spraul
    Laboratoire de Biochimie, CHU de Bicetre, Assistance Publique Hopitaux de Paris, 78, rue du General Leclerc, 94275 Le Kremlin Bicetre cedex, France et Université Paris XI, IFR Bicêtre, France
    Mol Genet Metab 94:443-7. 2008
  8. ncbi Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy
    Emmanuel Gonzales
    Pediatric Hepatology Unit, Hopital Bicetre, Assistance Publique Hopitaux de Paris, Paris, France
    Gastroenterology 137:1310-1320.e1-3. 2009
  9. ncbi Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease
    Gabriel Perlemuter
    Service d Hepato Gastroenterologie, Hopital Antoine Beclere, AP HP, 157 rue de la Porte de Trivaux, 92141 Clamart Cedex, France
    Liver Int 25:946-53. 2005
  10. ncbi NR1H4 analysis in patients with progressive familial intrahepatic cholestasis, drug-induced cholestasis or intrahepatic cholestasis of pregnancy unrelated to ATP8B1, ABCB11 and ABCB4 mutations
    Anne Davit-Spraul
    Biochemistry Laboratory, Bicetre Hospital, University of Paris Sud 11, Assistance Publique Hopitaux de Paris, Paris, France
    Clin Res Hepatol Gastroenterol 36:569-73. 2012

Collaborators

Detail Information

Publications11

  1. ncbi Simple and fast quantification of nitisone (NTBC) using liquid chromatography-tandem mass spectrometry method in plasma of tyrosinemia type 1 patients
    Anne Davit-Spraul
    Biochemistry Unit, Hopital Bicetre, Assistance Publique Hopitaux de Paris, Le Kremlin Bicetre, France
    J Chromatogr Sci 50:446-9. 2012
    ..The method was linear in the concentration range of 0.75-150 µM with r ≥ 0.998. Thus, this method is suitable for follow-up of patients treated with NTBC, because the current therapeutical concentrations range from 20 to 120 µM...
  2. ncbi Progressive familial intrahepatic cholestasis
    Anne Davit-Spraul
    Biochemistry, Bicetre Hospital, University of Paris Sud XI, Assistance Publique Hopitaux de Paris, Paris, France
    Orphanet J Rare Dis 4:1. 2009
    ..Hepatocyte transplantation, gene therapy or specific targeted pharmacotherapy may represent alternative treatments in the future...
  3. ncbi Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies
    Anne Davit-Spraul
    Biochemistry Unit, CHU Bicetre, Assistance Publique Hopitaux de Paris, France
    Mol Genet Metab 104:137-43. 2011
    ..Molecular analysis of GSD VI or IX genes allows to confirm diagnosis suspected on the basis of enzymatic analysis and to establish diagnosis and avoid liver biopsy when enzymatic studies are not informative in blood cells...
  4. ncbi ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history
    Anne Davit-Spraul
    Biochemistry Unit, Hopital Bicetre, Assistance Publique, Hopitaux de Paris, Paris, France
    Hepatology 51:1645-55. 2010
    ..CONCLUSION: PFIC1 and PFIC2 differ clinically, biochemically, and histologically at presentation and/or during the disease course. A small proportion of normal-GGT PFIC is likely not due to ATP8B1 or ABCB11 mutations...
  5. ncbi The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects
    Anne Davit-Spraul
    Biochemistry, University of Paris Sud 11, Assistance Publique Hopitaux de Paris, Le Kremlin Bicetre, France
    Semin Liver Dis 30:134-46. 2010
    ..The latter should be good candidates for a targeted pharmacologic approach and/or to cell therapy in the future...
  6. ncbi Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2
    Emmanuel Gonzales
    Pediatric Hepatology and National Reference Centre for Rare Pediatric Liver Diseases, Bicêtre Universitary Hospital, Faculty of Medicine Paris Sud, University of Paris Sud 11, Assistance Publique Hopitaux de Paris, Le Kremlin Bicetre, France
    J Hepatol 57:695-8. 2012
    ..After an in vitro study in a hepatocellular polarized line, we tested 4-PB treatment in a child with a homozygous p.T1210P BSEP mutation...
  7. ncbi Hereditary fructose intolerance: frequency and spectrum mutations of the aldolase B gene in a large patients cohort from France--identification of eight new mutations
    Anne Davit-Spraul
    Laboratoire de Biochimie, CHU de Bicetre, Assistance Publique Hopitaux de Paris, 78, rue du General Leclerc, 94275 Le Kremlin Bicetre cedex, France et Université Paris XI, IFR Bicêtre, France
    Mol Genet Metab 94:443-7. 2008
    ..R57P), c.839C>A (p.A280P) and c.932T>C (p.L311P)). Our strategy allows to diagnose 75% of HFI patients using restriction enzymatic analysis and to enlarge the diagnosis to 97% of HFI patients when associated with direct sequencing...
  8. ncbi Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy
    Emmanuel Gonzales
    Pediatric Hepatology Unit, Hopital Bicetre, Assistance Publique Hopitaux de Paris, Paris, France
    Gastroenterology 137:1310-1320.e1-3. 2009
    ..The aim of the study was to evaluate the long-term effectiveness and safety of cholic acid (CA) therapy...
  9. ncbi Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease
    Gabriel Perlemuter
    Service d Hepato Gastroenterologie, Hopital Antoine Beclere, AP HP, 157 rue de la Porte de Trivaux, 92141 Clamart Cedex, France
    Liver Int 25:946-53. 2005
    ....
  10. ncbi NR1H4 analysis in patients with progressive familial intrahepatic cholestasis, drug-induced cholestasis or intrahepatic cholestasis of pregnancy unrelated to ATP8B1, ABCB11 and ABCB4 mutations
    Anne Davit-Spraul
    Biochemistry Laboratory, Bicetre Hospital, University of Paris Sud 11, Assistance Publique Hopitaux de Paris, Paris, France
    Clin Res Hepatol Gastroenterol 36:569-73. 2012
    ..No NR1H4 mutation was found in PFIC patients. In one woman with ICP/DIC, a NR1H4 heterozygous variant (c.-1G>T) was found. This suggests that a NR1H4 mutation is not or rarely involved in hepatocellular cholestasis of unknown cause...
  11. ncbi Liver diseases related to MDR3 (ABCB4) gene deficiency
    Emmanuel Gonzales
    Pediatric Hepatology and National Reference Centre for Biliary Atresia, Bicetre Hospital, University of Paris South 11, AP HP, Paris, France
    Front Biosci 14:4242-56. 2009
    ..Some patients with MDR3 deficiency may benefit from ursodeoxycholic acid therapy and could be good candidates to a targeted pharmacological approach and/or to cell therapy in the future...